Taking pain killers during flu may up heart attack risk: study

Image
Press Trust of India Beijing
Last Updated : Feb 05 2017 | 3:28 PM IST
Taking pain relievers during a cold or flu-like illness may increase the risk of heart attack, a new study of 10,000 patients has warned.
Researchers at National Taiwan University Hospital in Taiwan suggest physicians and patients should use caution when prescribing or taking the medications, known as nonsteroidal anti-inflammatory drugs (NSAIDs), to ease symptoms of acute respiratory infections.
In an observational study, researchers analysed claims from Taiwan's National Health Insurance Programme over a seven-year period (2005-2011), including data from nearly 10,000 patients who were hospitalised for a heart attack.
The goal was to study whether two potential cardiac risk factors - an acute respiratory infection, such as a cold or influenza, and NSAID use - have a combined, joint effect on heart attack risk.
Researchers compared each patients' own risk for heart attack over time, across episodes of respiratory illness and NSAID use. They found a stronger association with a heart attack when both risk factors were present.
Using the pain relievers during an acute respiratory infection was associated with a 3.4-fold increased risk for a heart attack, with 7.2 times greater risk when patients received the pain-relieving medication intravenously in the hospital, compared to times when patients had neither of the risk factors.
The heart attack risk when patients with an acute respiratory illness were not taking an NSAID was 2.7 times greater, while the risk was 1.5 times greater when individuals took the drugs and did not have an infection.
Previous research has implicated respiratory infections and some NSAIDs as potential triggers for heart problems, but earlier studies have examined these risk factors only separately.
"Physicians should be aware that the use of NSAIDs during an acute respiratory infection might further increase the risk of a heart attack," said study author Cheng-Chung Fang, from National Taiwan University Hospital.
Patients seeking relief from cold and flu symptoms should consult with their doctor or a pharmacist before using NSAIDs, said Fang.
Another commonly used pain reliever, acetaminophen, which eases pain in a different way than NSAIDs do, may be a safer alternative, in terms of cardiac risk, for relief from cold and flu symptoms, although the drug was not evaluated in the study.
While the study's findings suggest an association between NSAID use, acute respiratory infections, and increased cardiac risk, they do not prove a cause-and-effect relationship.
Additional research is needed to clarify the apparent combined effect on risk and how the effect might be managed.
The study was published in the Journal of Infectious Diseases.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 05 2017 | 3:28 PM IST

Next Story